{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:59:19Z","timestamp":1790913559899,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":148,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["2024AH051959"],"award-info":[{"award-number":["2024AH051959"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014980","name":"Wannan Medical College","doi-asserted-by":"publisher","award":["WK2023ZZD26"],"award-info":[{"award-number":["WK2023ZZD26"]}],"id":[{"id":"10.13039\/501100014980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101270","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:52:54Z","timestamp":1780627974000},"page":"101270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emerging role of interaction between m6A and main ncRNAs in pancreatic cancer"],"prefix":"10.1016","volume":"48","author":[{"given":"Xingkai","family":"Rui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerui","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-7443","authenticated-orcid":false,"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101270_bib0001","article-title":"Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: a model-based period analysis","volume":"9","author":"Li","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.ctarc.2026.101270_bib0002","first-page":"9","article-title":"Intraoperative celiac axis flow measurement and dynamic surgical strategies in robotic distal pancreatectomy","volume":"9","author":"Loiaco","year":"2025","journal-title":"Mini-invasive Surg."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5152\/tjg.2024.24544","article-title":"Pancreatic cancer: current concepts, trends, and future directions","volume":"36","author":"Wenzel","year":"2024","journal-title":"Turk. J. Gastroenterol.: Off. J. Turk. Soc. Gastroenterol."},{"issue":"0","key":"10.1016\/j.ctarc.2026.101270_bib0004","first-page":"20","article-title":"Minimally invasive left pancreatectomy for pancreatic ductal adenocarcinoma: review of the current literature","volume":"8","author":"De Pastena","year":"2024","journal-title":"Mini-invasive Surg."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101270_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70318","article-title":"Global trend in pancreatic cancer prevalence rates through 2040: an illness-death modeling study","volume":"13","author":"Hesami","year":"2024","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0006","doi-asserted-by":"crossref","first-page":"820","DOI":"10.5114\/aoms.2020.94845","article-title":"The global burden of pancreatic cancer","volume":"16","author":"Lippi","year":"2020","journal-title":"Archiv. Med. Sci.: AMS"},{"issue":"48","key":"10.1016\/j.ctarc.2026.101270_bib0007","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.3748\/wjg.v28.i48.6827","article-title":"Clinical diagnosis and management of pancreatic cancer: markers, molecular mechanisms, and treatment options","volume":"28","author":"Zhang","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ctarc.2026.101270_bib0008","first-page":"32","article-title":"A narrative review of the history and recent advances in minimally invasive pancreatic resection","volume":"7","author":"Shannon","year":"2023","journal-title":"Mini-invasive Surg."},{"key":"10.1016\/j.ctarc.2026.101270_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.819044","article-title":"Genetic regulation of N6-methyladenosine-RNA in mammalian gametogenesis and embryonic development","volume":"10","author":"Chang","year":"2022","journal-title":"Front. Cell Dev. Biol"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12967-025-06221-y","article-title":"m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101270_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.778582","article-title":"Non-coding RNA m6A modification in cancer: mechanisms and therapeutic targets","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0012","first-page":"3963","article-title":"Role of non-coding RNA in pancreatic cancer","volume":"18","author":"Lv","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0013","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101270_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.702072","article-title":"Characterization of modification patterns, biological function, clinical implication, and immune microenvironment association of m(6)A regulators in pancreatic cancer","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Genet."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101270_bib0015","article-title":"The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion","volume":"215","author":"Xia","year":"2019","journal-title":"Pathol. Res. Pr."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101270_bib0016","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1038\/s44318-024-00213-2","article-title":"m(6)A mRNA methylation by METTL14 regulates early pancreatic cell differentiation","volume":"43","author":"Kahraman","year":"2024","journal-title":"EMBO J."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101270_bib0017","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.3390\/cancers14235919","article-title":"Targeting FTO suppresses pancreatic carcinogenesis via regulating stem cell maintenance and EMT pathway","volume":"14","author":"Garg","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101270_bib0018","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.7150\/ijbs.60115","article-title":"N(6)-methyladenosine (m(6)A) in pancreatic cancer: regulatory mechanisms and future direction","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","article-title":"The noncoding RNA revolution-trashing old rules to forge new ones","volume":"157","author":"Cech","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0021","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101270_bib0022","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.7150\/ijbs.104407","article-title":"The mechanism and latest progress of m6A methylation in the progression of pancreatic cancer","volume":"21","author":"Liu","year":"2025","journal-title":"Int. J. Biol. Sci"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101270_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110813","article-title":"SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine","volume":"39","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0024","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.gendis.2022.02.014","article-title":"N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2\/MYC axis","volume":"10","author":"Peng","year":"2023","journal-title":"Genes. Dis."},{"key":"10.1016\/j.ctarc.2026.101270_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112824","article-title":"The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression","volume":"140","author":"Wei","year":"2024","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.ctarc.2026.101270_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114839","article-title":"The roles and mechanism of m(6)A RNA methylation regulators in cancer immunity","volume":"163","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0027","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101270_bib0028","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.molcel.2019.05.030","article-title":"PCIF1 Catalyzes m6Am mRNA methylation to regulate gene expression","volume":"75","author":"Sendinc","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ctarc.2026.101270_bib0029","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m(6)A mRNA methylation in 3\u2032UTR and near stop codon and associates with alternative polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discov."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/cancers15041084","article-title":"RBM15 Promates the proliferation, migration and invasion of pancreatic cancer cell lines","volume":"15","author":"Dong","year":"2023","journal-title":"Cancers. (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0031","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1007\/s10528-023-10560-0","article-title":"FTO knockdown-mediated maturation of miR-383-5p inhibits malignant advancement of pancreatic cancer by targeting ITGA3","volume":"62","author":"Zhang","year":"2024","journal-title":"Biochem. Genet"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-020-01158-w","article-title":"RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner","volume":"19","author":"Guo","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101270_bib0033","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1016\/j.csbj.2022.11.045","article-title":"N(1)-methyladenosine modification in cancer biology: current status and future perspectives","volume":"20","author":"Li","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"5 Pt B","key":"10.1016\/j.ctarc.2026.101270_bib0034","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.bbagen.2016.11.031","article-title":"Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: a molecular mechanism involving G4 DNA","volume":"1861","author":"Cogoi","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101270_bib0035","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1158\/1535-7163.MCT-19-0822","article-title":"An RNA-binding protein, Hu-antigen R, in pancreatic cancer epithelial to mesenchymal transition, metastasis, and cancer stem cells","volume":"19","author":"Dong","year":"2020","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.ctarc.2026.101270_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2023.101948","article-title":"Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer","volume":"73","author":"Deng","year":"2024","journal-title":"Mol. Cell. Probes"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101270_bib0037","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/febs.13614","article-title":"N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases","volume":"283","author":"Maity","year":"2016","journal-title":"FEBS. J."},{"key":"10.1016\/j.ctarc.2026.101270_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108671","article-title":"Recent advances in the reciprocal regulation of m(6)A modification with non-coding RNAs and its therapeutic application in acute myeloid leukemia","volume":"259","author":"Yang","year":"2024","journal-title":"Pharmacol. Ther"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101270_bib0039","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s12276-023-00944-y","article-title":"The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications","volume":"55","author":"Liu","year":"2023","journal-title":"Exp. Mol. Med"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0040","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5452","article-title":"Role of N(6)\u2011methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)","volume":"62","author":"Ye","year":"2023","journal-title":"Int. J. Oncol"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101270_bib0041","first-page":"274","article-title":"Methylation of FAM110C is a synthetic lethal marker for ATR\/CHK1 inhibitors in pancreatic cancer","volume":"12","author":"Liu","year":"2024","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.ctarc.2026.101270_bib0042","first-page":"99","article-title":"MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1","volume":"9","author":"Lu","year":"2016","journal-title":"Onco Targets. Ther."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101270_bib0043","first-page":"1529","article-title":"METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity","volume":"46","author":"Zhu","year":"2023","journal-title":"Cell. Oncol. (Dordr. Neth.)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0044","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-020-01249-8","article-title":"Upregulation of METTL14 mediates the elevation of PERP mRNA N(6) adenosine methylation promoting the growth and metastasis of pancreatic cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0045","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41420-024-02020-4","article-title":"KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1\/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.ctarc.2026.101270_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216840","article-title":"Glycolysis and tumor progression promoted by the m(6)A writer VIRMA via m(6)A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma","volume":"590","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101270_bib0047","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1007\/s11033-022-07344-x","article-title":"Molecular mechanism of microRNAs regulating apoptosis in osteosarcoma","volume":"49","author":"Cai","year":"2022","journal-title":"Mol. Biol. Rep"},{"key":"10.1016\/j.ctarc.2026.101270_bib0048","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coph.2020.08.004","article-title":"MicroRNAs as mediators of drug resistance mechanisms","volume":"54","author":"Lampis","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101270_bib0049","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/cells13110948","article-title":"The multifaceted role of miR-21 in pancreatic cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ctarc.2026.101270_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121340","article-title":"The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: a review","volume":"316","author":"Farasati Far","year":"2023","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101270_bib0051","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.18632\/aging.102776","article-title":"TP53\/miR-34a-associated signaling targets SERPINE1 expression in human pancreatic cancer","volume":"12","author":"Akula","year":"2020","journal-title":"Aging (Albany. NY)"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101270_bib0052","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/MPA.0000000000001920","article-title":"MicroRNA-34a alleviates gemcitabine resistance in pancreatic cancer by repression of cancer stem cell renewal","volume":"50","author":"Pan","year":"2021","journal-title":"Pancreas."},{"key":"10.1016\/j.ctarc.2026.101270_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.672195","article-title":"Early dissemination of circulating tumor cells: biological and clinical insights","volume":"11","author":"Chemi","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101270_bib0054","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41419-018-0839-8","article-title":"MiR-361-3p regulates ERK1\/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma","volume":"9","author":"Hu","year":"2018","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.ctarc.2026.101270_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.965231","article-title":"The role of miR-200 family in the regulation of hallmarks of cancer","volume":"12","author":"Klicka","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101270_bib0056","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.omtn.2019.06.015","article-title":"Expression and role of MicroRNAs from the miR-200 Family in the Tumor formation and metastatic propensity of pancreatic cancer","volume":"17","author":"Diaz-Riascos","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ctarc.2026.101270_bib0057","article-title":"Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer","volume":"251","author":"Abulsoud","year":"2023","journal-title":"Pathol. Res. Pr."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0058","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNA biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0059","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.hbpd.2022.12.002","article-title":"Roles of lncRNAs in pancreatic ductal adenocarcinoma: diagnosis, treatment, and the development of drug resistance","volume":"22","author":"Jiang","year":"2023","journal-title":"Hepatobiliary Pancreat. Dis. Int.: HBPD INT"},{"key":"10.1016\/j.ctarc.2026.101270_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12935-019-0761-x","article-title":"Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer","volume":"19","author":"Jiang","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"7291","key":"10.1016\/j.ctarc.2026.101270_bib0061","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"issue":"18\u201320","key":"10.1016\/j.ctarc.2026.101270_bib0062","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1080\/17435889.2024.2367958","article-title":"Green-synthesized copper oxide nanoparticles induce apoptosis and up-regulate HOTAIR and HOTTIP in pancreatic cancer cells","volume":"19","author":"Hosseini","year":"2024","journal-title":"Nanomed. (L.)"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101270_bib0063","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/cas.15388","article-title":"Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer","volume":"113","author":"Cheng","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ctarc.2026.101270_bib0064","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.omtn.2021.08.024","article-title":"LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K\/AKT pathway","volume":"26","author":"Luo","year":"2021","journal-title":"Mol. Ther. Nucleic acids"},{"key":"10.1016\/j.ctarc.2026.101270_bib0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13578-017-0192-0","article-title":"Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p\/PTEN axis","volume":"7","author":"Gao","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ctarc.2026.101270_bib0066","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jare.2025.02.001","article-title":"Long non-coding RNAs: emerging regulators of invasion and metastasis in pancreatic cancer","volume":"78","author":"Shi","year":"2025","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0067","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.ctarc.2026.101270_bib0068","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101270_bib0069","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2020.04.014","article-title":"Hypoxia-induced lncRNA RP11-390F4.3 promotes epithelial-mesenchymal transition (EMT) and metastasis through upregulating EMT regulators","volume":"483","author":"Peng","year":"2020","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101270_bib0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2217\/epi-2023-0141","article-title":"circRNA: a promising all-around star in the future","volume":"15","author":"Li","year":"2023","journal-title":"Epigenomics."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0071","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/CBM-220229","article-title":"Hsa_circRNA_001859 regulates pancreatic cancer progression and epithelial-mesenchymal transition through the miR-21-5p\/SLC38A2 pathway","volume":"37","author":"Li","year":"2023","journal-title":"Cancer Biomark.: Sect. Dis. Markers"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0072","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/s12935-021-02392-y","article-title":"CircSEC24A upregulates TGFBR2 expression to accelerate pancreatic cancer proliferation and migration via sponging to miR-606","volume":"21","author":"Chen","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0073","first-page":"124","article-title":"Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p\/GOT1 axis in pancreatic cancer","volume":"40","author":"Zhou","year":"2021","journal-title":"J. Exp. Clin. Cancer Ees.: CR"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101270_bib0074","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/s12276-022-00877-y","article-title":"Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer","volume":"54","author":"Zhao","year":"2022","journal-title":"Exp. Mol. Med"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0075","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pan.2020.12.023","article-title":"Repression of circRNA_000684 inhibits malignant phenotypes of pancreatic ductal adenocarcinoma cells via miR-145-mediated KLF5","volume":"21","author":"Liu","year":"2021","journal-title":"Pancreatol.: off. J. Int. Assoc. Pancreatol. (IAP) [et al,]"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101270_bib0076","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.7150\/ijms.107773","article-title":"Circular RNA in pancreatic cancer: biogenesis, mechanism, function and clinical application","volume":"22","author":"Chen","year":"2025","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0077","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-023-01847-2","article-title":"circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-\u03b2 signalling pathway-mediated activation of MMPs in pancreatic cancer","volume":"22","author":"Zhao","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0078","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","article-title":"RNA-binding proteins in tumor progression","volume":"13","author":"Qin","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0079","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12943-022-01599-5","article-title":"CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2","volume":"21","author":"Meng","year":"2022","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41419-023-05570-0","article-title":"m(6)A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m(6)A\/PD-L1 manner","volume":"14","author":"Guan","year":"2023","journal-title":"Cell Death. Dis."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101270_bib0081","doi-asserted-by":"crossref","first-page":"14460","DOI":"10.1080\/21655979.2022.2088497","article-title":"N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer","volume":"13","author":"Jiang","year":"2022","journal-title":"Bioengineered."},{"key":"10.1016\/j.ctarc.2026.101270_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.955486","article-title":"MicroRNA-383: a tumor suppressor miRNA in human cancer","volume":"10","author":"Jafarzadeh","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0083","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13277-015-4346-6","article-title":"MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers","volume":"37","author":"Nagaraju","year":"2016","journal-title":"Tumour Biol.: J. Int. Soc. Oncodevelopmental Biol. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101270_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189219","article-title":"Epigenetic regulation of TGF-\u03b2 and vice versa in cancers - A review on recent developments","volume":"1879","author":"Naik","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101270_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117347","article-title":"Flavonoids as modulators of miRNA expression in pancreatic cancer: pathways, mechanisms, and therapeutic potential","volume":"179","author":"Helen","year":"2024","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0086","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cas.16380","article-title":"Recent advances in noncoding RNA modifications of gastrointestinal cancer","volume":"116","author":"Hara","year":"2025","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101270_bib0087","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3390\/cancers16122179","article-title":"Extracellular vesicular miRNA in pancreatic cancer: from lab to therapy","volume":"16","author":"Tiwari","year":"2024","journal-title":"Cancers."},{"key":"10.1016\/j.ctarc.2026.101270_bib0088","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1480572","article-title":"Deciphering the role of NcRNAs in pancreatic cancer immune evasion and drug resistance: a new perspective for targeted therapy","volume":"15","author":"Gong","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101270_bib0089","article-title":"N6-methyladenosine reader YTHDF family in biological processes: structures, roles, and mechanisms","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101270_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28243","article-title":"IGF2BP2-related modification patterns in pancreatic cancer: a machine learning-driven approach towards personalized treatment","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0091","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12935-023-03181-5","article-title":"LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p\/SPP1 axis as a ceRNA","volume":"24","author":"Ouyang","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101270_bib0092","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41418-023-01225-x","article-title":"LncRNA BCAN-AS1 stabilizes c-myc via N(6)-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer","volume":"30","author":"Wu","year":"2023","journal-title":"Cell Death. Differ."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0093","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12032-025-02643-2","article-title":"Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets","volume":"42","author":"Suliman","year":"2025","journal-title":"Med. Oncol"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0094","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12885-024-11885-8","article-title":"Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma","volume":"24","author":"Li","year":"2024","journal-title":"BMC. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.21873\/cgp.20451","article-title":"CircRNAs in pancreatic cancer: new tools for target identification and therapeutic intervention","volume":"21","author":"Weidle","year":"2024","journal-title":"Cancer Genom. Proteom."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101270_bib0096","article-title":"Coding circular RNA in human cancer","volume":"12","author":"Lin","year":"2025","journal-title":"Genes. Dis."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0097","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","article-title":"N6-Methyladenosine modification controls circular RNA immunity","volume":"76","author":"Chen","year":"2019","journal-title":"Mol. Cell"},{"issue":"Pt 1","key":"10.1016\/j.ctarc.2026.101270_bib0098","article-title":"Exosomal non-coding RNA: a new frontier in diagnosing and treating pancreatic cancer: a review","volume":"263","author":"Sha","year":"2024","journal-title":"Int. J. Biol, Macromol"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101270_bib0099","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41417-024-00786-4","article-title":"Hsa_circ_0007590\/PTBP1 complex reprograms glucose metabolism by reducing the stability of m(6)A-modified PTEN mRNA in pancreatic ductal adenocarcinoma","volume":"31","author":"Zheng","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13073-021-01002-w","article-title":"Genome-wide identification and characterization of circular RNA m(6)A modification in pancreatic cancer","volume":"13","author":"Ye","year":"2021","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0101","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2478\/jtim-2022-0003","article-title":"Basic pancreatic lesions: radiologic-pathologic correlation","volume":"10","author":"Bian","year":"2022","journal-title":"J. Transl. Intern. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101270_bib0102","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/abbs\/gmz048","article-title":"Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA","volume":"51","author":"Huang","year":"2019","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0103","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1021\/acs.analchem.5b03962","article-title":"Determination of DNA and RNA methylation in circulating tumor cells by mass spectrometry","volume":"88","author":"Huang","year":"2016","journal-title":"Anal, Chem"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0104","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/clinchem\/hvz004","article-title":"Level of N6-methyladenosine in peripheral blood RNA: a novel predictive biomarker for gastric cancer","volume":"66","author":"Ge","year":"2020","journal-title":"Clin. Chem"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101270_bib0106","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s12276-022-00795-z","article-title":"Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types","volume":"54","author":"Oh","year":"2022","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.ctarc.2026.101270_bib0107","article-title":"The value of circulating tumor cells in the prognosis and treatment of pancreatic cancer","volume":"12","author":"Luo","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0108","doi-asserted-by":"crossref","first-page":"305","DOI":"10.14701\/ahbps.2018.22.4.305","article-title":"ALKBH5 gene is a novel biomarker that predicts the prognosis of pancreatic cancer: a retrospective multicohort study","volume":"22","author":"Cho","year":"2018","journal-title":"Ann. Hepato-biliary-pancreat. Surg."},{"key":"10.1016\/j.ctarc.2026.101270_bib0109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2025.01.072","article-title":"Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis","volume":"380","author":"Hasan","year":"2025","journal-title":"J. Control. Release: off. J. Control. Release Soc."},{"key":"10.1016\/j.ctarc.2026.101270_bib0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1477-7819-11-219","article-title":"Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma","volume":"11","author":"Que","year":"2013","journal-title":"World J. Surg. Oncol."},{"issue":"7311","key":"10.1016\/j.ctarc.2026.101270_bib0111","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature09284","article-title":"OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma","volume":"467","author":"Medina","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0112","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12885-018-4006-5","article-title":"An elevated expression of serum exosomal microRNA-191, -\u200921, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker","volume":"18","author":"Goto","year":"2018","journal-title":"BMC. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101270_bib0113","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3892\/ol.2020.11691","article-title":"Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer","volume":"20","author":"Wu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ctarc.2026.101270_bib0114","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.mie.2015.03.001","article-title":"Transcriptome-wide mapping of N\u2076-methyladenosine by m\u2076A-Seq","volume":"560","author":"Dominissini","year":"2015","journal-title":"Meth. Enzym."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/gpbjnl\/qzae052","article-title":"Pan-cancer analysis reveals m6A variation and cell-specific regulatory network in different cancer types","volume":"22","author":"Lin","year":"2024","journal-title":"Genom. Proteom. Bioinform."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101270_bib0116","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000875","article-title":"Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer","volume":"4","author":"McAndrews","year":"2021","journal-title":"Life Sci. Alliance"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101270_bib0117","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70415","article-title":"Cancer-associated fibroblasts: origin, classification, tumorigenicity, and targeting for Cancer therapy","volume":"6","author":"Fan","year":"2025","journal-title":"MedComm"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0118","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2478\/jtim-2022-0022","article-title":"Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma","volume":"11","author":"Shen","year":"2023","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.ctarc.2026.101270_bib0119","article-title":"Prognostic and clinicopathological significance of circular RNA circ-ITCH expression in cancer patients: a meta-analysis","volume":"2021","author":"Sun","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101270_bib0120","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41467-019-09712-x","article-title":"Excessive miR-25-3p maturation via N(6)-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101270_bib0121","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.chembiol.2023.09.001","article-title":"Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy","volume":"31","author":"Yu","year":"2024","journal-title":"Cell Chem. Biol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:51:40Z","timestamp":1790913100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":121,"alternative-id":["S2468294226001814"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101270","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of interaction between m6A and main ncRNAs in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101270"}}